Northwire Canada EditionFriday, July 10, 2026
Northwire
NNX 0.035 +0.0% ABX 51.84 −0.7% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.28 +11.9% TUNG 1.74 +3.0% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.52 +1.4% SGZ 0.040 −11.1% S 0.165 +37.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% NNX 0.035 +0.0% ABX 51.84 −0.7% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.28 +11.9% TUNG 1.74 +3.0% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.52 +1.4% SGZ 0.040 −11.1% S 0.165 +37.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0%
Other

Liberty Defense lands Hexwave lab screening contract

SCAN · Price

Executive Summary

  • Liberty Defense Holdings Ltd. secured a contract to deploy its Hexwave™ walkthrough screening system at a world-class infectious disease research laboratory, following a successful on-site trial.
  • The Hexwave system utilizes active millimeter-wave imaging and AI to detect metallic and non-metallic threats without slowing personnel flow, integrating with existing security infrastructure.
  • The company also announced that its amended 2025 Omnibus Incentive Plan was approved by shareholders on December 12, 2025, and received final approval from the TSX Venture Exchange, replacing the prior plan entirely.

Key Details

  • Contract Award: Sale secured with a well-known infectious disease laboratory for the deployment of Hexwave™ walkthrough screening systems.
  • Deployment Scope: Systems will screen both employees and visitors entering/exiting the facility to enhance safety and threat detection.
  • Technology Specifications: Hexwave combines active millimeter-wave imaging with artificial intelligence to detect concealed threats including metallic/non-metallic items, liquids, gels, powders, ceramics, and emerging materials.
  • Operational Benefits: Enables fast, contactless, high-volume screening while allowing everyday items to remain on the person; integrates with existing security, video, and access-control systems.
  • Selection Process: Award resulted from a successful on-site trial and collaboration focused on meeting rigorous screening standards.
  • Shareholder Approval: Amended Omnibus Incentive Plan approved at the Annual General Meeting held on December 12, 2025.
  • Regulatory Approval: Plan received final approval from the TSX Venture Exchange.
  • Plan Terms:
    • Authorizes grants of stock options, restricted share units (RSUs), and deferred share units (DSUs).
    • Maximum number of common shares issuable under the plan (plus other share compensation arrangements) shall not exceed 10% of the company's outstanding common shares at any time.
    • Replaces the company's prior omnibus incentive plan in its entirety; all existing equity awards are now governed by the 2025 plan terms.
  • Plan Availability: Copy of the plan available under the company's profile on SEDAR+.

Notable Quotes

  • "We continue to diversify our custom clientele with Hexwave, especially with organizations where safety and security are paramount," said Bill Frain, chief executive officer of Liberty Defense. "This award came after a successful on-site trial, and our continued collaboration with the customer focused on meeting their rigorous screening standards. Hexwave delivers the advanced detection performance they require -- identifying both metallic and non-metallic threats critical to maintaining a secure laboratory environment."
Read the original news release →

More from Liberty Defense Holdings Ltd